Please log in to view this page
Username
Password
HPTN 069 is a phase II, four-arm, multisite, randomized, double-blinded trial. To assess the safety and tolerability of four...
A5314 is a phase II randomized, double-blind, placebo-controlled 36-week trial that will examine the safety and efficacy of...
Many factors contribute to the development of aging-related conditions, including gastrointestinal (GI) diseases, such as...
The investigators are looking for a better way to prevent cervical cancer. This study is comparing two different methods to...
The purpose of this study is to evaluate the safety, tolerability, and effect of an experimental human monoclonal antibody...
